Dashboard
Manage Tickers

ONCT Oncternal Therapeutics, Inc.

Nasdaq oncternal.com


$ -0.17 (-24.11 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 603.31 $ 4.22 (0.71 %)
DIA $ 463.45 $ 0.00 (0 %)
SPY $ 665.93 $ 2.94 (0.44 %)
TLT $ 90.72 $ -0.20 (-0.22 %)
GLD $ 387.39 $ 6.60 (1.73 %)
$ 0.5266
-- x --
-- x --
-- - --
$ 0.53 - $ 13.14
702,150
na
1.56M
$ 1.60
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2024 09-30-2024 10-Q
2 08-08-2024 06-30-2024 10-Q
3 05-09-2024 03-31-2024 10-Q
4 03-07-2024 12-31-2023 10-K
5 11-09-2023 09-30-2023 10-Q
6 08-10-2023 06-30-2023 10-Q
7 05-04-2023 03-31-2023 10-Q
8 03-09-2023 12-31-2022 10-K
9 11-03-2022 09-30-2022 10-Q
10 08-09-2022 06-30-2022 10-Q
11 05-05-2022 03-31-2022 10-Q
12 03-10-2022 12-31-2021 10-K
13 11-04-2021 09-30-2021 10-Q
14 08-05-2021 06-30-2021 10-Q
15 05-06-2021 03-31-2021 10-Q
16 03-11-2021 12-31-2020 10-K
17 11-04-2020 09-30-2020 10-Q
18 08-06-2020 06-30-2020 10-Q
19 05-07-2020 03-31-2020 10-Q
20 03-16-2020 12-31-2019 10-K
21 11-08-2019 09-30-2019 10-Q
22 08-09-2019 06-30-2019 10-Q
23 05-10-2019 03-31-2019 10-Q
24 03-18-2019 12-31-2018 10-K
25 11-08-2018 09-30-2018 10-Q
26 08-14-2018 06-30-2018 10-Q
27 05-15-2018 03-31-2018 10-Q
28 03-13-2018 12-31-2017 10-K
29 11-14-2017 09-30-2017 10-Q
30 08-14-2017 06-30-2017 10-Q
31 05-15-2017 03-31-2017 10-Q
32 03-24-2017 12-31-2016 10-K
33 11-07-2016 09-30-2016 10-Q
34 08-09-2016 06-30-2016 10-Q
35 05-10-2016 03-31-2016 10-Q
36 03-15-2016 12-31-2015 10-K
37 11-09-2015 09-30-2015 10-Q
38 08-10-2015 06-30-2015 10-Q
39 05-11-2015 03-31-2015 10-Q
40 03-16-2015 12-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
11/25/2024 21:05:40

gold-down-over-3-rigetti-computing-shares-spike-higher
Gold Down Over 3%; Rigetti Computing Share...
11/25/2024 19:18:59

crude-oil-down-3-chicago-fed-national-activity-index-falls-in-october
Crude Oil Down 3%; Chicago Fed National Ac...
11/25/2024 17:35:38

dow-surges-over-300-points-bath--body-works-posts-upbeat-earnings
Dow Surges Over 300 Points; Bath & Body Wo...
11/25/2024 14:47:44

on-november-22-oncternal-therapeutics-announced-that-nasdaq-plans-to-delist-its-stock-on-december-3-nasdaq-classified-the-company-as-public-shell--following-its-decision-to-lay-off-employees-and-explore-strategic-alternatives-filing
On November 22, Oncternal Therapeutics Ann...
11/25/2024 11:30:45

Nasdaq will file a delisting notice with the SEC. Oncternal has stated it will not appeal the decision. 

oncternal-therapeutics-announced-workforce-reduction-effective-december-2-2024-four-employees-will-remain-in-a-part-time-capacity-in-connection-with-exploration-of-strategic-alternatives-expects-24m-in-charges-from-workforce-reduction
Oncternal Therapeutics Announced Workforce...
11/14/2024 22:15:52

oncternal-therapeutics-has-been-granted-us-patent-number-12128026-titled-selective-androgen-receptor-degrader-ligands-and-methods-of-use-thereof-for-the-treatment-of-prostate-cancer
Oncternal Therapeutics Has Been Granted U....
10/29/2024 19:17:58

https://ppubs.uspto.gov/pubwebapp/external.html?q=(12128026).pn

oncternal-therapeutics-announces-updated-safety-and-efficacy-data-for-phase-12-study-of-onct-534-for-the-treatment-of-rr-metastatic-castration-resistant-prostate-cancer
Oncternal Therapeutics Announces Updated S...
10/22/2024 13:14:58

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) (the "Company") today announced updated data from its Phase 1/2 Study of ONC...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
10/15/2024 12:08:20

northland-capital-markets-downgrades-oncternal-therapeutics-to-market-perform-announces-2-price-target
Northland Capital Markets Downgrades Oncte...
09/12/2024 19:49:17

Northland Capital Markets analyst Carl Byrnes downgrades Oncternal Therapeutics (NASDAQ:ONCT) from Outperform to Market Perf...

dow-surges-over-100-points-modivcare-shares-plummet
Dow Surges Over 100 Points; ModivCare Shar...
09/12/2024 18:01:18

crude-oil-surges-3-kroger-posts-upbeat-earnings
Crude Oil Surges 3%; Kroger Posts Upbeat E...
09/12/2024 16:10:01

brookline-capital-downgrades-oncternal-therapeutics-to-hold
Brookline Capital Downgrades Oncternal The...
09/12/2024 15:16:58

Brookline Capital analyst Kemp Dolliver downgrades Oncternal Therapeutics (NASDAQ:ONCT) from Buy to Hold.

us-stocks-mixed-producer-prices-increase-in-august
US Stocks Mixed; Producer Prices Increase ...
09/12/2024 14:23:57

trading-halt-halt-status-updated-at-94000-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 9:40:...
09/12/2024 13:40:05

oncternal-therapeutics-to-discontinue-clinical-trials-for-onct-534-and-onct-808-due-to-lack-of-clinically-meaningful-results-and-high-capital-requirements-company-to-explore-strategic-alternatives-including-asset-sales-licensing-or-mergers-while-reducing-workforce-to-preserve-cash-resources
Oncternal Therapeutics To Discontinue Clin...
09/12/2024 13:01:48

trading-halt-halted-at-85500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 8:55:00 a.m. ET - ...
09/12/2024 12:55:04

hc-wainwright--co-maintains-buy-on-oncternal-therapeutics-lowers-price-target-to-18
HC Wainwright & Co. Maintains Buy on Oncte...
08/12/2024 09:52:15

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Oncternal Therapeutics (NASDAQ:ONCT) with a Buy and lowers the ...

oncternal-therapeutics-q2-2024-gaap-eps-289-beats-310-estimate-sales-801000k-beat-237500k-estimate
Oncternal Therapeutics Q2 2024 GAAP EPS $(...
08/08/2024 20:24:23

Oncternal Therapeutics (NASDAQ:ONCT) reported quarterly losses of $(2.89) per share which beat the analyst consensus estimate o...

hc-wainwright--co-reiterates-buy-on-oncternal-therapeutics-maintains-19-price-target
HC Wainwright & Co. Reiterates Buy on Onct...
07/16/2024 11:53:03

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Oncternal Therapeutics (NASDAQ:ONCT) with a Buy and maintains ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION